75N93024C00008
Definitive Contract
Overview
Government Description
TO DEVELOP A NOVEL MODULATOR TARGETING PROTEOSTASIS FOR THE TREATMENT OF M. TUBERCULOSIS.
Awarding / Funding Agency
Place of Performance
New York, NY 10005 United States
Pricing
Cost No Fee
Set Aside
None
Extent Competed
Full And Open Competition
Est. Average FTE
14
Related Opportunity
Analysis Notes
Subcontracting Plan This Definitive Contract has an Individual Subcontract Plan. The Department of Health and Human Services has an overall small business subcontracting goal of 32%
The Global Alliance For Tb Drug Development was awarded
Definitive Contract 75N93024C00008 (75N930-24-C-00008)
for To Develop A Novel Modulator Targeting Proteostasis For The Treatment Of M. Tuberculosis.
worth up to $9,851,406
by the National Institute of Allergy and Infectious Diseases
in May 2024.
The contract
has a duration of 4 years and
was awarded
through solicitation 2023 NIAID Omnibus Broad Agency Announcement
full & open
with
NAICS 541715 and
PSC AN12
via direct negotiation acquisition procedures with 18 bids received.
As of today, the Definitive Contract has a total reported backlog of $7,375,783.
Status
(Open)
Last Modified 5/9/24
Period of Performance
5/10/24
Start Date
11/9/25
Current End Date
4/30/28
Potential End Date
Obligations and Backlog
$2.5M
Total Obligated
$2.5M
Current Award
$9.9M
Potential Award
$0.0
Funded Backlog
$7.4M
Total Backlog
Award Hierarchy
Definitive Contract
75N93024C00008
Subcontracts
Activity Timeline
Opportunity Lifecycle
Procurement history for 75N93024C00008
People
Suggested agency contacts for 75N93024C00008
Competition
Number of Bidders
18
Solicitation Procedures
Negotiated Proposal/Quote
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item Procedures Not Used
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Individual Subcontract Plan
Cost Accounting Standards
Yes
Business Size Determination
Large Business
Awardee UEI
CA1RNRESAZU6
Awardee CAGE
52VM4
Agency Detail
Awarding Office
75N930 NATIONAL INSTITUTES OF HEALTH NIAID
Funding Office
75N930
Created By
hhsteosl
Last Modified By
hhsteosl
Approved By
hhsteosl
Legislative
Legislative Mandates
None Applicable
Performance District
NY-10
Senators
Kirsten Gillibrand
Charles Schumer
Charles Schumer
Representative
Dan Goldman
Modified: 5/9/24